Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility
2024

Effects of GLP-1-based Therapies on Gut Motility

publication Evidence: moderate

Author Information

Author(s): Jalleh Ryan, Marathe Chinmay S, Rayner Christopher K, Jones Karen L, Umapathysivam Mahesh M, Wu Tongzhi, Quast Daniel R, Plummer Mark P, Nauck Michael A, Horowitz Michael

Primary Institution: Royal Adelaide Hospital, Adelaide, Australia

Hypothesis

How do GLP-1-based therapies affect gastric, biliary, and intestinal motility?

Conclusion

GLP-1-based therapies slow gastric emptying and have complex effects on gastrointestinal motility, which can influence postprandial glucose levels and energy intake.

Supporting Evidence

  • GLP-1-based therapies improve glycemic control and promote weight loss.
  • These therapies can slow gastric emptying, which may lower post-meal blood sugar spikes.
  • Clinical trials show that GLP-1 receptor agonists have cardiovascular and renal protective effects.
  • Slower gastric emptying can lead to reduced energy intake and increased feelings of fullness.

Takeaway

GLP-1 medications help control blood sugar and weight by slowing down how fast food leaves the stomach, which can also affect how hungry you feel.

Methodology

The review summarizes existing studies on the effects of GLP-1-based therapies on gastrointestinal motility.

Limitations

Many studies used suboptimal methods to measure gastric emptying.

Digital Object Identifier (DOI)

10.1210/endocr/bqae155

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication